NEW YORK and TORONTO, July 31, 2020 /PRNewswire/ – iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN) (OTCQX: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, reports its financial results for the year ended December 31, 2019. The Company’s Financial Statements for the year ended December 31, 2019 and the related Management’s Discussion & Analysis can be accessed on the Company’s SEDAR profile at www.sedar.com and on the Company’s website.

SILVER SPRING, Md., July 31, 2020 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older. Epidiolex was previously approved for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS). This is the only FDA-approved drug that contains a purified drug substance derived from cannabis. It is also the second FDA approval of a drug for the treatment of seizures associated with TSC.

LAVAL, QC, le 31 juill. 2020 /CNW Telbec/ – Neptune Solutions Bien-être inc. (« Neptune » ou la « Société ») (NASDAQ : NEPT) (TSX : NEPT), une société diversifiée et entièrement intégrée axée sur la santé et le bien-être qui propose des marques naturelles, végétales, durables et portées par une mission, a annoncé aujourd’hui qu’elle publiera ses résultats financiers du premier trimestre de l’exercice 2021 après la clôture des marchés financiers le mardi 11 août 2020.

TORONTO, July 30, 2020 /PRNewswire/ – Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSX: RIV) (OTC: CNPOF) will report its first quarter fiscal year 2021 financial results before markets open on August 14, 2020. The Company’s unaudited condensed interim consolidated financial statements and management’s discussion and analysis of financial results for the three months ended June 30, 2020 will be available on the Company’s profile on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com and on the Company’s website at www.canopyrivers.com/investors.

Infused Beverage Expert Signs Definitive Agreement with Maritime-based Licensed Distributor to Exclusively Represent BevCanna’s Products in Newfoundland, Prince Edward Island and New Brunswick

VANCOUVER, BC, July 27, 2020 /CNW/ – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company”) announces the appointment of Shai Altman as President and Chief Executive Officer (“CEO”) of the Company, relieving Kevin Coft, Interim CEO, from that position effective 1 September, 2020.